+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Gardner Syndrome Treatment Market Report 2026 - Product Thumbnail Image

Gardner Syndrome Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Generic Pharmaceuticals Market Report 2026 - Product Thumbnail Image

Generic Pharmaceuticals Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Melanoma Therapeutics: Global Markets - Product Thumbnail Image

Melanoma Therapeutics: Global Markets

  • Report
  • November 2023
  • 131 Pages
  • Global
From
Biotechnology Market - Global Forecast 2023-2030 - Product Thumbnail Image

Biotechnology Market - Global Forecast 2023-2030

  • Report
  • March 2024
  • 241 Pages
  • Global
From
From
Intrahepatic Cholangiocarcinoma (ICC) - Pipeline Insight, 2025 - Product Thumbnail Image

Intrahepatic Cholangiocarcinoma (ICC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Protein Engineering Market 2026-2030 - Product Thumbnail Image

Protein Engineering Market 2026-2030

  • Report
  • January 2026
  • 294 Pages
  • Global
From
From
Rare Diseases Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Rare Diseases Treatment Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 196 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2020-2026 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2020-2026

  • Report
  • March 2026
  • 1200 Pages
  • Global
From
Loading Indicator